Quoin Pharmaceuticals, Ltd. (QNRX)
NASDAQ: QNRX · Real-Time Price · USD
0.620
-0.006 (-0.90%)
Nov 21, 2024, 4:00 PM EST - Market closed
Quoin Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 3 | 5 | 7 | 15 | - | - |
| Market Cap Growth | -52.12% | -29.65% | -54.69% | - | - | - |
| Enterprise Value | -4 | -5 | -4 | 21 | - | - |
| Last Close Price | 0.63 | 4.91 | 17.04 | 273.00 | - | - |
| PB Ratio | 0.58 | 0.85 | 0.93 | 23.12 | - | - |
| P/TBV Ratio | 0.40 | 0.95 | 1.03 | - | - | - |
| Debt / Equity Ratio | 0.56 | 0.62 | 0.56 | 7.19 | -0.18 | - |
| Quick Ratio | 2.97 | 2.99 | 3.64 | 1.64 | 0.04 | - |
| Current Ratio | 3.02 | 3.15 | 3.79 | 1.79 | 0.06 | - |
| Return on Equity (ROE) | -135.37% | -132.92% | -232.68% | - | - | - |
| Return on Assets (ROA) | -44.13% | -44.03% | -48.59% | -70.60% | -87.18% | - |
| Return on Capital (ROIC) | -59.56% | -56.58% | -68.43% | - | - | - |
| Earnings Yield | -273.55% | -179.39% | -136.29% | -141.27% | - | - |
| FCF Yield | -278.06% | -162.41% | -123.20% | -37.65% | - | - |
| Buyback Yield / Dilution | -336.80% | -346.38% | -666.91% | -31.43% | - | - |
| Total Shareholder Return | -336.80% | -346.38% | -666.91% | -31.43% | - | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.